Inventory is where supply chain meets cash flow. Run too lean and you face stockouts that erode practice and provider confidence; run too heavy and you tie up cash and risk product reaching its re-test or expiry window.
This guide lays out a simple, practical approach to planning peptide inventory in a clinic without overcomplicating it.
Start with demand, not guesswork
Base your plan on actual usage. Track how much of each SKU moves per month, watch for seasonality and growth trends, and let real numbers — not vibes — set your reorder points. Even a simple spreadsheet of monthly usage per SKU beats reordering reactively.
Lead times and safety stock
Your reorder point is driven by how long an order takes to arrive. Add a safety-stock buffer to cover demand spikes and supplier delays. Suppliers that keep a core catalog in stock and ship in one to two business days let you carry less safety stock without risking stockouts.
Rotate lots and watch re-test dates
• • Use first-in, first-out so older lots move before newer ones.
• • Track each lot's re-test or expiry window so product doesn't quietly age out.
• • Keep the lot-matched COA on file for every lot in stock.
Reorder points, written as arithmetic
A reorder point is consumption during the lead time plus a buffer for the variability of both. Average weekly use multiplied by lead time in weeks, plus safety stock. A compound used at two vials a week on a four-week lead time reorders at eight vials plus buffer.
Research material adds a constraint ordinary inventory maths does not have: it degrades while it waits. That puts a ceiling on stock as well as a floor, and the ceiling is whatever can be used inside the material usable window. Inventory levels and reorder points works the arithmetic through, and retest dates and expiry dates covers what that window actually is.
When the supplier minimum exceeds your ceiling
This is the awkward and common case: the smallest order available is more than you can use before the material ages out. Buying it anyway is not a saving, it is waste purchased at full price.
Three honest responses. Order less often and accept the gaps. Consolidate across compounds so one order clears the minimum, since many minimums are per order rather than per line. Or reconsider whether the item belongs in the formulary at all. Minimum order quantities explains why the floor sits where it does.
Avoid both stockouts and overstock
The goal is balance: enough to never disappoint a provider, not so much that cash sits on a shelf or product expires. Review your numbers monthly, adjust reorder points as demand shifts, and lean on a supplier whose reliability lets you plan tighter.
Source from a supplier that tests every batch.
Seven-layer testing, a lot-matched COA with every order, made in the USA, white-label fulfillment. Verify your NPI for instant wholesale access.
First expiry, first out, and why it needs labels
Where several lots of one compound are held, the one closest to its retest date should be drawn on first. That sounds obvious and fails constantly, because the lot nearest the front of the tray is the one that gets picked up. The rule only works if the date is readable without handling each vial, which makes it a labelling problem before it is an inventory one.
Two practical fixes carry most of the benefit. Write the retest date on the outward-facing surface in a position consistent across every vial, so a glance down a row is enough. And separate lots physically rather than mixing them in one tray, because a mixed tray silently defeats any rotation rule. Labeling and identification covers making a vial readable after it leaves the box.
What to count, and how often
A full count quarterly and a spot check monthly suits most practices. The full count reconciles physical stock against the record, which is the only way to find the slow leak that no single transaction explains. The spot check covers the fast-moving items where an error compounds quickest.
Three questions turn a count into a decision rather than an audit. Which items were ordered urgently, because that says the reorder point is too low. Which were discarded unused, because that says the ceiling was exceeded. And which have not moved at all since the last count, because that says the item may not belong in stock.
Lead time is two numbers, not one
Suppliers quote one lead time and deliver two. An item held in stock ships in days. An item made to order waits for a synthesis slot, purification and release testing, which is weeks. Planning against a single blended figure guarantees being wrong in both directions: over-ordering the fast items and under-ordering the slow ones.
Ask for both figures explicitly and record which applies to each line in your formulary. The difference also changes what a stockout costs, because a stocked item can be recovered in days while a made-to-order item cannot be recovered at all inside a month.
What inventory planning cannot fix
It cannot make material last longer, and it cannot substitute for knowing how the material was stored. A perfectly planned inventory of vials that spent a week at room temperature is a well-counted problem. Storage records and inventory records answer different questions and both are needed.
Nor can it resolve a supplier minimum that exceeds what you can use. That is a procurement decision rather than a planning one, and the honest responses are to order less often, consolidate across compounds, or drop the item. Buying material that will age out is not a saving however neatly it is counted.
For how this fits with everything else that happens to a vial between delivery and use, peptide storage and handling for clinics covers the full picture.